Search Within

Weining Ma

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (10)
  2. Meeting Abstract (3)
Groups
  1. Biostatistics Service (13)
  2. Body Imaging Service (13)
  3. Department of Medicine (13)
  4. Epidemiology and Biostatistics (13)
  5. Radiology, Department of (13)
  6. Solid Tumor Oncology Division (12)

More Groups

People
  1. Alexia Iasonos (8)
  2. Qin Zhou (6)
  3. Carol Aghajanian (5)
  4. Nadeem Abu-Rustum (4)
  5. Vicky Makker (4)
  6. Britta Weigelt (3)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Clinical Cancer Research (2)
  2. Gynecologic Oncology (2)
  3. Journal of Clinical Oncology (2)
  4. American Journal of Obstetrics and Gynecology (1)
  5. American Journal of Roentgenology (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (3)
  4. American Roentgen Ray Society (1)
  5. FEBS Press (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ERBB2 mutations define a subgroup of endometrial carcinomas associated with high tumor mutational burden and the microsatellite instability-high (MSI-H) molecular subtype
    Journal Article

    Brodeur, M. N.; Selenica, P.; Ma, W.; Moufarrij, S.; Dagher, C.; Basili, T.; Abu-Rustum, N. R.; Aghajanian, C.; Zhou, Q.; Iasonos, A.; more...
    Molecular Oncology (2024)

    Fulltext@MSK | Save
  • HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer
    Journal Article

    Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
    Modern Pathology (2023)

    Fulltext@MSK | Save
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Ma, W.; Espino, K.; Gordhandas, S.; Yeoshoua, E.; Ehmann, S.; Zhou, Q.; Iasonos, A.; Abu-Rustum, N. R.; Aghajanian, C.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Clinicopathologic and molecular features associated with response to anti-HER2 therapy in endometrial cancer
    Meeting Abstract

    Shen, S.; Ma, W.; Zhou, Q.; Iasonos, A.; Zhang, Y.; Ross, D. S.; Makker, V.; Chui, M. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles
    Journal Article

    Manning-Geist, B. L.; Liu, Y. L.; Devereaux, K. A.; Da Cruz Paula, A.; Zhou, Q. C.; Ma, W.; Selenica, P.; Ceyhan-Birsoy, O.; Moukarzel, L. A.; Hoang, T.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Bevacizumab in advanced endometrial cancer
    Journal Article

    Rubinstein, M. M.; Dickinson, S.; Narayan, P.; Zhou, Q.; Iasonos, A.; Ma, W.; Lakhman, Y.; Makker, V.
    Gynecologic Oncology (2021)

    Fulltext@MSK | Save
  • Measuring tumor epichaperome expression using [(124)I] PU-H71 positron emission tomography as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2-negative metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; dos Anjos, C. H.; Taldone, T.; Wang, R.; Comen, E.; Fornier, M.; Bromberg, J. F.; Ma, W.; Patil, S.; Rodina, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Tumor epichaperome expression using (124)I PU-H71 PET (PU-PET) as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2 negative (HER2-) metastatic breast cancer (MBC)
    Meeting Abstract

    Jhaveri, K.; Dunphy, M.; Wang, R.; Comen, E.; Fornier, M.; Moynahan, M. E.; Bromberg, J.; Ma, W.; Patil, S.; Taldone, T.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Ovarian vein thrombosis after debulking surgery for ovarian cancer: Epidemiology and clinical significance
    Journal Article

    Mantha, S.; Sarasohn, D.; Ma, W.; Devlin, S. M.; Chi, D. S.; Roche, K. L.; Suidan, R. S.; Woo, K.; Soff, G. A.
    American Journal of Obstetrics and Gynecology (2015)

    Fulltext@MSK | Save